In bovine retinal endothelial cells, bovine retinal pericytes, and an animal model, candesartan attenuated vascular damage in diabetic retinopathy by restoring Glo1 activity and mRNA for Glo1 to at least control levels. Here, GLO1 is linked to diabetic retinopathy.